FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Schlaepfer

Research Profile

Procedures

Disorders

Concepts & Ideas

Anatomy

Activities & Behaviors

Image Processing, Computer-Assisted

Co-author Network

Publications

TOP 3
Bettina H Bewernick; Thomas Schlaepfer
Chronic depression as a model disease for cerebral aging.
Matthis Synofzik; Joseph J Fins; Thomas Schlaepfer
A neuromodulation experience registry for deep brain stimulation studies in psychiatric research: rationale and recommendations for implementation.
Bettina H Bewernick; Sarah Kayser; Volker Sturm; Thomas Schlaepfer
Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Schlaepfer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bettina H Bewernick; Thomas Schlaepfer
Chronic depression as a model disease for cerebral aging.
Dialogues in clinical neuroscience 2013;15(1):77-85.
2012: Matthis Synofzik; Joseph J Fins; Thomas Schlaepfer
A neuromodulation experience registry for deep brain stimulation studies in psychiatric research: rationale and recommendations for implementation.
Brain stimulation 2012;5(4):653-5.
2012: Bettina H Bewernick; Sarah Kayser; Volker Sturm; Thomas Schlaepfer
Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(9):1975-85.
2012: Martin Schaefer; Thomas Schlaepfer; Ulrich Spengler; Hans Weidenbach; Stefan Zeuzem; Thomas F Baumert; Peter Buggisch; Thomas Discher; Susanne Effenberger; Astrid Friebe; Gwendolyn Fromm; Andreas Heinz; Loni Heinze; Viola Knop; Klaus Lieb; Ralph Link; Konrad Neumann; Johann Ockenga; Jens Reimer; Michael Rentrop; Rahul Sarkar; Thomas Berg
Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Annals of internal medicine 2012;157(2):94-103.
2012: Benjamin Becker; Justin S Feinstein; Merve Aydin; Keith M Kendrick; Wolfram S Kunz; Wolfgang Maier; Andreas Matusch; Yoan Mihov; Ana-Maria Oros-Peusquens; Harald Reich; Dirk Scheele; Thomas Schlaepfer; Nadim J Shah; Horst Urbach; Karl Zilles; René Hurlemann
Fear processing and social networking in the absence of a functional amygdala.
Biological psychiatry 2012;72(1):70-7.
2012: Oezguer A Onur; Alexandra Patin; Thomas Schlaepfer; Birgit Stoffel-Wagner; Henrik Walter; Boris Buecher; Wolfgang Maier; Yoan Mihov; René Hurlemann
Overnight deprivation from smoking disrupts amygdala responses to fear.
Human brain mapping 2012;33(6):1407-16.
2012: Thomas Schlaepfer; Hans Agren; Cristobal Gasto; Palmiero Monteleone; David J Nutt; William Pitchot; Frederick Rouillon; Siegfried Kasper
The hidden third: improving outcome in treatment-resistant depression.
Journal of psychopharmacology (Oxford, England) 2012;26(5):587-602.
2012: Volker A Coenen; Niels Allert; Thomas Schlaepfer; Burkhard Mädler
Diffusion tensor imaging and neuromodulation: DTI as key technology for deep brain stimulation.
International review of neurobiology 2012;107():207-34.
2012: Paul E Holtzheimer; Markus Kosel; Thomas Schlaepfer
Brain stimulation therapies for neuropsychiatric disease.
Handbook of clinical neurology 2012;106():681-95.
2011: Guy M Goodwin; Heinz Grunze; Edith Holsboer-Trachsler; Rasmus W Licht; William Pitchot; Thomas Schlaepfer; Mocrane Abbar; Hans Ågren; Frank Bellivier; Alfredo Carlo Altamura; Konstantinos N Fountoulakis; Eduard Vieta
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance.
Current medical research and opinion 2011;27(12):2285-99.
2011: Christiane Grubert; Barbara Hadrysiewicz; René Hurlemann; Sarah Kayser; Nikolai Axmacher; Bettina H Bewernick; Volker Sturm; Thomas Schlaepfer
Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(7):516-27.
2011: A G Wade; G M Crawford; L Haazen; A McConnachie; Charles Nemeroff; A F Schatzberg; Thomas Schlaepfer; E Buntinx
Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
Psychological medicine 2011;41(10):2089-97.
2011: Volker A Coenen; Burkhard Maedler; Thomas Schlaepfer; Jaak Panksepp
Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans.
Neuroscience and biobehavioral reviews 2011;35(9):1971-81.
2011: Joseph J Fins; Thomas Schlaepfer; Bart Nuttin; Cynthia S Kubu; Thorsten Galert; Volker Sturm; Reinhard Merkel; Helen S Mayberg
Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation.
Journal of neural engineering 2011;8(3):033001.
2011: Sarah Kayser; Bettina H Bewernick; Christiane Grubert; Barbara L Hadrysiewicz; Nikolai Axmacher; Thomas Schlaepfer
Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression.
Journal of psychiatric research 2011;45(5):569-76.
2011: Tanja Schmitz-Hübsch; Mathieu Coudert; Sophie Tezenas du Montcel; Paola Giunti; Robyn Labrum; Alexandra Dürr; Pascale Ribai; Perrine Charles; Christoph Linnemann; Ludger Schöls; Maryla Rakowicz; Rafal Rola; Elszbieta Zdzienicka; Roberto Fancellu; Caterina Mariotti; Lazlo Baliko; Bela Melegh; Alessandro Filla; Elena Salvatore; Bart P C van de Warrenburg; Sandra Szymanski; Jon Infante; Dagmar Timmann; Sylvia Boesch; Chantal Depondt; Jun-Suk Kang; Jörg B Schulz; Thomas Klopstock; Nicole Lossnitzer; Bernd Löwe; Caroline Frick; Daniela Rottländer; Thomas Schlaepfer; Thomas Klockgether
Depression comorbidity in spinocerebellar ataxia.
Movement disorders : official journal of the Movement Disorder Society 2011;26(5):870-6.
2011: Markus Kosel; Holger Brockmann; Caroline Frick; Astrid Zobel; Thomas Schlaepfer
Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex.
Psychiatry research 2011;191(3):153-9.
2011: Joseph J Fins; Helen S Mayberg; Bart Nuttin; Cynthia S Kubu; Thorsten Galert; Volker Sturm; Katja Stoppenbrink; Reinhard Merkel; Thomas Schlaepfer
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder.
Health affairs (Project Hope) 2011;30(2):302-11.
2011: Markus Kosel; Andras Bilkei-Gorzo; Rainer Zawatzky; Andreas Zimmer; Thomas Schlaepfer
Pegylated human interferon alpha 2a does not induce depression-associated changes in mice.
Psychiatry research 2011;185(1-2):243-7.
2011: Thomas Schlaepfer; Bettina Bewernick; Sarah Kayser; Diane Lenz
Modulating affect, cognition, and behavior - prospects of deep brain stimulation for treatment-resistant psychiatric disorders.
Frontiers in integrative neuroscience 2011;5():29.
2011: Matthis Synofzik; Thomas Schlaepfer
Electrodes in the brain--ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders.
Brain stimulation 2011;4(1):7-16.
2010: Oezguer A Onur; Thomas Schlaepfer; Juraj Kukolja; Andreas Bauer; Haang Jeung; Alexandra Patin; David-Marian Otte; N Jon Shah; Wolfgang Maier; Keith M Kendrick; Gereon R Fink; René Hurlemann
The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans.
Biological psychiatry 2010;67(12):1205-11.
2010: Malek Bajbouj; Angela Merkl; Thomas Schlaepfer; Caroline Frick; Astrid Zobel; Wolfgang Maier; Veronica O'Keane; Ciaran Corcoran; Rolf Adolfsson; Michael Trimble; Harald Rau; Hans-Joachim Hoff; Frank Padberg; Florian Müller-Siecheneder; Kurt Audenaert; Dirk van den Abbeele; Keith Matthews; David Christmas; Sam Eljamel; Isabella Heuser
Two-year outcome of vagus nerve stimulation in treatment-resistant depression.
Journal of clinical psychopharmacology 2010;30(3):273-81.
2010: Thomas Schlaepfer; S H Lisanby; Stefano Pallanti
Separating hope from hype: some ethical implications of the development of deep brain stimulation in psychiatric research and treatment.
CNS spectrums 2010;15(5):285-7.
2010: Nikolai Axmacher; Michael X Cohen; Juergen Fell; Sven Haupt; Matthias Dümpelmann; Christian E Elger; Thomas Schlaepfer; Doris Lenartz; Volker Sturm; Charan Ranganath
Intracranial EEG correlates of expectancy and memory formation in the human hippocampus and nucleus accumbens.
Neuron 2010;65(4):541-9.
2010: Thomas Schlaepfer; Joseph J Fins
Deep brain stimulation and the neuroethics of responsible publishing: when one is not enough.
JAMA : the journal of the American Medical Association 2010;303(8):775-6.
2010: Thomas Schlaepfer; Mark Stork George; Helen S Mayberg
WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(1):2-18.
2010: Bettina H Bewernick; René Hurlemann; Andreas Matusch; Sarah Kayser; Christiane Grubert; Barbara Hadrysiewicz; Nikolai Axmacher; Matthias Lemke; Deirdre Cooper-Mahkorn; Michael X Cohen; Holger Brockmann; Doris Lenartz; Volker Sturm; Thomas Schlaepfer
Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression.
Biological psychiatry 2010;67(2):110-6.
2009: S H Lisanby; Stefano Pallanti; Thomas Schlaepfer
FDA considers classification of ECT.
CNS spectrums 2009;14(12):668-70.
2009: Peter V Rabins; Brian STEPHEN Appleby; Jason Brandt; Mahlon R DeLong; Laura B Dunn; Loes Gabriëls; Benjamin D Greenberg; Suzanne N Haber; Paul E Holtzheimer; ZOLTAN MARI; Helen S Mayberg; Evelyn McCann; Sallie P Mink; Steven Rasmussen; Thomas Schlaepfer; Dorothy E Vawter; Jerrold L Vitek; John T Walkup; Debra J H Mathews
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought.
Archives of general psychiatry 2009;66(9):931-7.
2009: Michael X Cohen; Nikolai Axmacher; Doris Lenartz; Christian E Elger; Volker Sturm; Thomas Schlaepfer
Nuclei accumbens phase synchrony predicts decision-making reversals following negative feedback.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(23):7591-8.
2009: Oezguer A Onur; Henrik Walter; Thomas Schlaepfer; Anne K Rehme; Christoph Schmidt; Christian Keysers; Wolfgang Maier; René Hurlemann
Noradrenergic enhancement of amygdala responses to fear.
Social cognitive and affective neuroscience 2009;4(2):119-26.
2009: Michael X Cohen; Nikolai Axmacher; Doris Lenartz; Christian E Elger; Volker Sturm; Thomas Schlaepfer
Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(7):1649-58.
2009: Sarah Kayser; Bettina Bewernick; Nikolai Axmacher; Thomas Schlaepfer
Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder.
The journal of ECT 2009;25(2):137-40.
2009: Michael X Cohen; Nikolai Axmacher; Doris Lenartz; Christian E Elger; Volker Sturm; Thomas Schlaepfer
Good vibrations: cross-frequency coupling in the human nucleus accumbens during reward processing.
Journal of cognitive neuroscience 2009;21(5):875-89.
2009: Clinton D Kilts; Alan G Wade; Henning F Andersen; Thomas Schlaepfer
Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
Expert opinion on pharmacotherapy 2009;10(6):927-36.
2009: René Hurlemann; Thomas Schlaepfer; Andreas Matusch; Harald Reich; N Jon Shah; Karl Zilles; Wolfgang Maier; Andreas Bauer
Reduced 5-HT(2A) receptor signaling following selective bilateral amygdala damage.
Social cognitive and affective neuroscience 2009;4(1):79-84.
2009: A G Wade; Thomas Schlaepfer; H F Andersen; Clinton D Kilts
Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
Journal of psychiatric research 2009;43(5):568-75.
2009: Mark Stork George; Frank Padberg; Thomas Schlaepfer; John P O'Reardon; Paul B Fitzgerald; Ziad Nahas; Marco A Marcolin
Controversy: Repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder).
Brain stimulation 2009;2(1):14-21.
2009: Tanja Schmitz-Hübsch; Thomas Schlaepfer; Jens Westheide; Marcus von Falkenhausen; Deirdre Cooper-Mahkorn; Wolfgang Maier; Kai-Uwe Kühn
Clozapine: acquittal of the usual suspect.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):981-4.
2009: Thomas Schlaepfer; B H Bewernick
Deep brain stimulation for psychiatric disorders--state of the art.
Advances and technical standards in neurosurgery 2009;34():37-57.
2008: Matthis Synofzik; Thomas Schlaepfer
Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes.
Biotechnology journal 2008;3(12):1511-20.
2008: Juraj Kukolja; Thomas Schlaepfer; Christian Keysers; Dietrich Klingmüller; Wolfgang Maier; Gereon R Fink; René Hurlemann
Modeling a negative response bias in the human amygdala by noradrenergic-glucocorticoid interactions.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(48):12868-76.
2008: Thomas Schlaepfer; Caroline Frick; A Zobel; W Maier; I Heuser; Malek Bajbouj; V O'Keane; C Corcoran; R Adolfsson; M Trimble; H Rau; H-J Hoff; F Padberg; F Müller-Siecheneder; K Audenaert; D Van den Abbeele; K Matthews; D Christmas; Zeno Stanga; M Hasdemir
Vagus nerve stimulation for depression: efficacy and safety in a European study.
Psychological medicine 2008;38(5):651-61.
2008: Markus Kosel; Roger S Noss; Robert Hämmig; Peter Wielepp; Petra Bundeli; Rebeca Heidbreder; Jane A Kinser; Rudolf Brenneisen; Hans U Fisch; Sarah Kayser; Thomas Schlaepfer
Cerebral blood flow effects of acute intravenous heroin administration.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(4):278-85.
2008: Thomas Schlaepfer; Michael X Cohen; Caroline Frick; Markus Kosel; Daniela Brodesser; Nikolai Axmacher; Alexius Young Joe; Martina Kreft; Doris Lenartz; Volker Sturm
Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(2):368-77.
2007: S Guyer; Markus Kosel; S Altrichter; Marwan El-Koussy; Robert Haemmig; Hans U Fisch; Karl-Olof Lovblad; Thomas Schlaepfer
Pattern of regional cerebral blood-flow changes induced by acute heroin administration--a perfusion MRI study.
Journal of neuroradiology. Journal de neuroradiologie 2007;34(5):322-9.
2007: Thomas Schlaepfer
[Brain stimulation methods for resistance to therapy].
Der Nervenarzt 2007;78 Suppl 3():575-81; quiz 582-3.
2007: Markus Kosel; Volker Sturm; Caroline Frick; Doris Lenartz; Gabriele Zeidler; Daniela Brodesser; Thomas Schlaepfer
Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression.
Journal of psychiatric research 2007;41(9):801-3.
2006: Klaus Lieb; Thomas Schlaepfer
Deep-brain stimulation for Parkinson's disease.
The New England journal of medicine 2006;355(21):2256; author reply 2256.
2006: Michael Wagner; Tonia A Rihs; Urs P Mosimann; Hans U Fisch; Thomas Schlaepfer
Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex affects divided attention immediately after cessation of stimulation.
Journal of psychiatric research 2006;40(4):315-21.
2006: Thomas Schlaepfer; Eric Lancaster; Rebecca Heidbreder; Eric C Strain; Markus Kosel; Hans U Fisch; Godfrey D Pearlson
Decreased frontal white-matter volume in chronic substance abuse.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(2):147-53.
2005: Thomas Schlaepfer; Klaus Lieb
Deep brain stimulation for treatment of refractory depression.
Lancet 2005;366(9495):1420-2.
2005: Caroline Frick; Markus Kosel; Thomas Schlaepfer; Zeno Stanga; Mustafa G Hasdemir
Incident mania during therapy with vagus nerve stimulation.
The journal of ECT 2005;21(3):197.
2005: Svenja C Schulze-Rauschenbach; Uta Harms; Thomas Schlaepfer; Wolfgang Maier; Peter Falkai; Michael Wagner
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression.
The British journal of psychiatry : the journal of mental science 2005;186():410-6.
2005: Michael Wagner; Boris B Quednow; Jens Westheide; Thomas Schlaepfer; Wolfgang Maier; Kai-Uwe Kühn
Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(2):381-90.
2004: Thomas Schlaepfer
Learning from the history of neuroscience: dogma and patient interests: comment to Dr. Finks commentary.
The journal of ECT 2004;20(3):137-8; discussion 138.
2004: Paul E Holtzheimer; David H Avery; Thomas Schlaepfer
Antidepressant effects of repetitive transcranial magnetic stimulation.
The British journal of psychiatry : the journal of mental science 2004;184():541-2.
2004: Urs P Mosimann; Wolfgang Schmitt; Benjamin D Greenberg; Markus Kosel; René Martin Mueri; Magdalena Berkhoff; Christian W Hess; Hans U Fisch; Thomas Schlaepfer
Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients.
Psychiatry research 2004;126(2):123-33.
2004: Markus Kosel; Uwe Rudolph; Peter Wielepp; Martin Luginbühl; Wolfgang Schmitt; Hans U Fisch; Thomas Schlaepfer
Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(2):347-50.
2003: Markus Kosel; Caroline Frick; Sarah H Lisanby; Hans U Fisch; Thomas Schlaepfer
Magnetic seizure therapy improves mood in refractory major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(11):2045-8.
2003: Sarah H Lisanby; Bruce Luber; Thomas Schlaepfer; Harold A Sackeim
Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(10):1852-65.
2003: Markus Kosel; Thomas Schlaepfer
Beyond the treatment of epilepsy: new applications of vagus nerve stimulation in psychiatry.
CNS spectrums 2003;8(7):515-21.
2003: Bob Belmaker; Paul Fitzgerald; Mark Stork George; Sarah H Lisanby; Alvar Pascual-Leone; Thomas Schlaepfer; Eric M Wassermann
Managing the risks of repetitive transcranial stimulation.
CNS spectrums 2003;8(7):489.
2003: José Luis R Martin; Manel J Barbanoj; Thomas Schlaepfer; Elinor Thompson; Víctor Pérez; Jaime Kulisevsky
Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis.
The British journal of psychiatry : the journal of mental science 2003;182():480-91.
2003: Mark Stork George; Ziad Nahas; Sarah H Lisanby; Thomas Schlaepfer; F Andrew Kozel; Benjamin D Greenberg
Transcranial magnetic stimulation.
Neurosurgery clinics of North America 2003;14(2):283-301.
2003: Thomas Schlaepfer; Markus Kosel; Charles Nemeroff
Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(2):201-5.
2002: Markus Kosel; Thomas Schlaepfer
Mechanisms and state of the art of vagus nerve stimulation.
The journal of ECT 2002;18(4):189-92.
2002: Urs P Mosimann; Susanne C Marré; Stefan Werlen; Wolfgang Schmitt; Christian W Hess; Hans U Fisch; Thomas Schlaepfer
Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance.
Archives of general psychiatry 2002;59(6):560-1.
2002: René Martin Mueri; Robert Bühler; D Heinemann; Urs P Mosimann; Jacques Felblinger; Thomas Schlaepfer; Christian W Hess
Hemispheric asymmetry in visuospatial attention assessed with transcranial magnetic stimulation.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 2002;143(4):426-30.
2002: J L Martin; Manel J Barbanoj; Thomas Schlaepfer; Susana Clos; V Perez; Jaime Kulisevsky; Alexandre Gironell
Transcranial magnetic stimulation for treating depression.
Cochrane database of systematic reviews (Online) 2002;(2):CD003493.
2001: Rudolf Hoehn-Saric; Thomas Schlaepfer; Benjamin D Greenberg; Daniel R McLeod; Godfrey D Pearlson; Steven H Y Wong
Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders.
Psychiatry research 2001;108(2):89-100.
2001: M Wipfli; Jacques Felblinger; Urs P Mosimann; Christian W Hess; Thomas Schlaepfer; René Martin Mueri
Double-pulse transcranial magnetic stimulation over the frontal eye field facilitates triggering of memory-guided saccades.
The European journal of neuroscience 2001;14(3):571-5.
2001: T Graf; J Engeler; P Achermann; Urs P Mosimann; R Noss; Hans U Fisch; Thomas Schlaepfer
High frequency repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral cortex: EEG topography during waking and subsequent sleep.
Psychiatry research 2001;107(1):1-9.
2001: Daniel S Mojon; Thomas Schlaepfer
[Nonorganic disorders in ophthalmology: overview of diagnosis and therapy].
Klinische Monatsblätter für Augenheilkunde 2001;218(5):298-304.
2001: Sarah H Lisanby; Thomas Schlaepfer; Hans U Fisch; H A Sackeim
Magnetic seizure therapy of major depression.
Archives of general psychiatry 2001;58(3):303-5.
2000: Urs P Mosimann; Tonia A Rihs; J Engeler; Hans U Fisch; Thomas Schlaepfer
Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers.
Psychiatry research 2000;94(3):251-6.
2000: Thomas Schlaepfer
[Alcohol and the brain--morphological and functional brain changes].
Therapeutische Umschau. Revue thérapeutique 2000;57(4):191-5.
1998: RR Ji; Thomas Schlaepfer; Carlos D Aizenman; C M Epstein; D Qiu; J C Huang; F Rupp
Repetitive transcranial magnetic stimulation activates specific regions in rat brain.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(26):15635-40.
1998: William W Eaton; James C Anthony; Alan Romanoski; Allen Tien; J Gallo; G Cai; Karin Neufeld; Thomas Schlaepfer; J Laugharne; LS Chen
Onset and recovery from panic disorder in the Baltimore Epidemiologic Catchment Area follow-up.
The British journal of psychiatry : the journal of mental science 1998;173():501-7.
1998: Allen Tien; Thomas Schlaepfer; W Orr; Godfrey D Pearlson
SPECT brain blood flow changes with continuous ligand infusion during previously learned WCST performance.
Psychiatry research 1998;82(1):47-52.
1998: Thomas Schlaepfer; Eric C Strain; Benjamin D Greenberg; Kenzie L. Preston; E Lancaster; George E Bigelow; Patrick Barta; Godfrey D Pearlson
Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
The American journal of psychiatry 1998;155(4):470-3.
1998: Allen Tien; Thomas Schlaepfer; Hans U Fisch
Self-reported somatization symptoms associated with risk for extreme alcohol use.
Archives of family medicine 1998;7(1):33-7.
1997: Thomas Schlaepfer; Godfrey D Pearlson; Dean F Wong; S Marenco; Robert F Dannals
PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.
The American journal of psychiatry 1997;154(9):1209-13.
1997: Benjamin D Greenberg; Mark Stork George; J D Martin; J Benjamin; Thomas Schlaepfer; Margaret Altemus; Eric M Wassermann; R M Post; Dennis L Murphy
Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study.
The American journal of psychiatry 1997;154(6):867-9.
1997: Godfrey D Pearlson; Thomas Schlaepfer
Sex differences in schizophrenia.
Archives of general psychiatry 1997;54(2):189.
1996: Allen Tien; T V Spevack; D W Jones; Godfrey D Pearlson; Thomas Schlaepfer; M E Strauss
Computerized Wisconsin Card Sorting Test: comparison with manual administration.
The Kaohsiung journal of medical sciences 1996;12(8):479-85.
1996: Allen Tien; William W Eaton; Thomas Schlaepfer; I K McGilchrist; R Menon; R Powers; Elizabeth H Aylward; Patrick Barta; M E Strauss; Godfrey D Pearlson
Exploratory factor analysis of MRI brain structure measures in schizophrenia.
Schizophrenia research 1996;19(2-3):93-101.
1995: Thomas Schlaepfer; Godfrey D Pearlson
Pitfalls of SPECT studies of acute ethanol-induced changes in cerebral blood flow.
The American journal of psychiatry 1995;152(11):1695-6.
1995: Thomas Schlaepfer; G J Harris; Allen Tien; L Peng; S Lee; Godfrey D Pearlson
Structural differences in the cerebral cortex of healthy female and male subjects: a magnetic resonance imaging study.
Psychiatry research 1995;61(3):129-35.
1995: Elizabeth H Aylward; P D Brettschneider; justin charles mcarthur; G J Harris; Thomas Schlaepfer; Jeffrey D Henderer; Patrick Barta; Allen Tien; Godfrey D Pearlson
Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia.
The American journal of psychiatry 1995;152(7):987-94.
1994: Thomas Schlaepfer; G J Harris; Allen Tien; L W Peng; S Lee; E B Federman; G A Chase; Patrick Barta; Godfrey D Pearlson
Decreased regional cortical gray matter volume in schizophrenia.
The American journal of psychiatry 1994;151(6):842-8.
1994: G J Harris; Thomas Schlaepfer; L W Peng; S Lee; E B Federman; Godfrey D Pearlson
Magnetic resonance imaging evaluation of the effects of ageing on grey-white ratio in the human brain.
Neuropathology and applied neurobiology 1994;20(3):290-3.
1994: G J Harris; Patrick Barta; L W Peng; S Lee; P D Brettschneider; A Shah; Jeffrey D Henderer; Thomas Schlaepfer; Godfrey D Pearlson
MR volume segmentation of gray matter and white matter using manual thresholding: dependence on image brightness.
AJNR. American journal of neuroradiology 1994;15(2):225-30.
1993: P Widler; H U Fisch; P Schoch; Arthur Zimmermann; Thomas Schlaepfer; Jürg Reichen
Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat.
Hepatology (Baltimore, Md.) 1993;18(6):1459-64.
1992: Thomas Schlaepfer; P Bärtsch; H U Fisch
Paradoxical effects of mild hypoxia and moderate altitude on human visual perception.
Clinical science (London, England : 1979) 1992;83(5):633-6.
1991: Thomas Schlaepfer; M Groner; E Lavoyer; H U Fisch
Visual masking: a reliable measure for the assessment of cognitive dysfunction in the elderly?
Journal of gerontology 1991;46(4):P157-61.
1989: Godfrey D Pearlson; L Kreger; Peter V Rabins; G A Chase; B Cohen; JAMES WIRTH; Thomas Schlaepfer; Larry E Tune
A chart review study of late-onset and early-onset schizophrenia.
The American journal of psychiatry 1989;146(12):1568-74.
1988: Thomas Schlaepfer; H U Fisch
[HIV infection of the central nervous system: psychiatric consequences].
Schweizerische medizinische Wochenschrift 1988;118(16):571-6.